NCT01948869View on ClinicalTrials.gov

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Dermatitis, Atopic
Interventions
DEVICE

Phoenix II (BAY81-2996)

DEVICE

Phoenix I (BAY81-2996)

Trial Locations (1)

48155

Münster

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01948869 - Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis | Biotech Hunter | Biotech Hunter